Trent Wang

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Corey Cutler, Stephanie J. Lee, Sally Arai et al. · Blood · 2021 · 295 citations · Full text

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

Yucai Wang, Preetesh Jain, Frederick L. Locke et al. · Journal of Clinical Oncology · 2023 · 155 citations · Full text

Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT)

George Nahas, Krishna V. Komanduri, Denise Pereira et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 101 citations

Immunodeficiencies, T-regulatory Cell, Immunology +24

Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

Carrie L. Kitko, Mukta Arora, Zachariah DeFilipp et al. · Journal of Clinical Oncology · 2022 · 88 citations · Full text

Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant

Michael Scordo, Trent Wang, Kwang Woo Ahn et al. · JAMA Oncology · 2021 · 74 citations · Full text